Patients with diabetes mellitus have> 2× the risk for develo** heart failure (HF; HF with
reduced ejection fraction and HF with preserved ejection fraction). Cardiovascular …

Type 1 and type 2 diabetes mellitus is a serious and lifelong condition commonly
characterised by abnormally elevated blood glucose levels due to a failure in insulin …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ABCD= adiposity-based chronic disease; ACCORD= Action to Control …

Background Metformin is the most widely prescribed drug to lower glucose and has a
definitive effect on the cardiovascular system. The goal of this systematic review and meta …

Type 2 diabetes mellitus (T2DM) is an expanding global health problem, closely linked to
the epidemic of obesity. Individuals with T2DM are at high risk for both microvascular …

ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ACCORD= Action to Control Cardiovascular Risk in Diabetes; ACCORD …

Background: Clinicians and patients need updated evidence on the comparative
effectiveness and safety of diabetes medications to make informed treatment choices …

Diabetes causes cardiomyopathy and increases the risk of heart failure independent of
hypertension and coronary heart disease. This condition called “Diabetic Cardiomyopathy” …

Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …